Onconetix, Inc. Amortization of Intangible Assets
Onconetix, Inc. (ONCO) reported Amortization of Intangible Assets of $709.04 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-03-13
- Onconetix, Inc. amortization of intangible assets for the quarter ending 2024-12-31 was $113.04K.
- Onconetix, Inc. amortization of intangible assets for the quarter ending 2024-09-30 was $198.00K.
- Onconetix, Inc. amortization of intangible assets for the quarter ending 2024-06-30 was $196.00K.
- Onconetix, Inc. amortization of intangible assets for fiscal 2024 was $709.04K, a 1826.12% increase from fiscal 2023.
- Onconetix, Inc. amortization of intangible assets for fiscal 2023 was $36.81K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2024-12-31 | $113.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $311.04K derived: sum of 2 quarters · filed 2026-03-13 | $507.04K derived: sum of 3 quarters · filed 2026-03-13 | $709.04K 10-K · filed 2026-03-13 |
| 2024-09-30 | $198.00K 10-Q · filed 2024-12-10 | $394.00K derived: sum of 2 quarters · filed 2024-12-10 | $596.00K 10-Q · filed 2024-12-10 | |
| 2024-06-30 | $196.00K 10-Q · filed 2024-08-29 | $398.00K 10-Q · filed 2024-08-29 | ||
| 2023-12-31 | $36.81K 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |